SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?


To: Bluegreen who wrote (9013)3/9/1999 5:46:00 AM
From: xomadog2  Read Replies (1) | Respond to of 17367
 
The consent to provide the drug on an open label basis is a signal that the DSMB feel as well as the FDA,that by not providing the drug at all and just ending the trial,children who need the drug wont get it,therefore,if everyone who meets the criteria and comes into the trial would get the drug on an open label basis.

It would be a plus for the stock,....approval would be even better.!!